Story perspectives

Amazon Launches Affordable GLP-1 Weight Management Program

4/22/2026

Summary

Story summary

Amazon One Medical launched a GLP-1 weight management program combining virtual and in-person visits, prescription management, and pharmacy fulfillment.
Insured patients pay as low as $25 per month, while cash-paying customers would pay $149 for oral drugs and $299 for injectables.
Following the announcement, shares of Eli Lilly and Novo Nordisk fell.
The program leverages Amazon's logistics to offer same-day delivery and expand access to GLP-1 medications.

History

Historical Context

The FDA's 2017 approval of the first GLP-1 receptor agonist marked a significant advancement in diabetes and obesity treatment, following decades of research on GLP-1 hormones. By 2022, Eli Lilly and Novo Nordisk reported over $4 billion in combined revenues, reflecting the growing market. Amazon's new program aims to improve access to these medications, highlighting the evolving landscape of pharmaceutical distribution and telehealth.

1 of 2

Story summary

Amazon One Medical launched a GLP-1 weight management program combining virtual and in-person visits, prescription management, and pharmacy fulfillment.
Insured patients pay as low as $25 per month, while cash-paying customers would pay $149 for oral drugs and $299 for injectables.
Following the announcement, shares of Eli Lilly and Novo Nordisk fell.
The program leverages Amazon's logistics to offer same-day delivery and expand access to GLP-1 medications.

1 / 2